Most patients with localized appendix cancer may be able to safely avoid chemotherapy after surgery, according to a new study from researchers at The University of Texas MD Anderson Cancer Center.
A study found that less than 10% of patients relapsed after surgery, and chemotherapy given afterwards was not associated with improved survival or a lower risk of relapse,